Montenegro vs Yemen: Pneumococcal conjugate second or third-dose vaccines (PCVc)
Montenegro
28.0%
in 2025
Yemen
39.0%
in 2025
Montenegro rank
162nd
Yemen rank
160th
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Montenegro
- Yemen
How they compare
Yemen currently reports 39.0% against 28.0% in Montenegro, a difference of 11.0%.
That makes Yemen's figure about 1.4 times Montenegro's.
Across all 18 years both countries report, Yemen has been ahead every year.
Montenegro ranks 162nd and Yemen ranks 160th of 194 countries.
Yemen has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Montenegro | Yemen | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | — |
| 2010s | 0.0% | 54.0% | 54.0% | Yemen |
| 2020s | 4.7% | 48.7% | 44.0% | Yemen |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Montenegro or Yemen?
- Yemen, at 39.0% against 28.0% in Montenegro as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Montenegro and Yemen?
- 11.0%, with Yemen ahead.
- How many years of comparable data are there for Montenegro and Yemen?
- 18 years are reported by both, from 2008 to 2025.
- How do Montenegro and Yemen rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Montenegro ranks 162nd and Yemen ranks 160th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.